We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Evelo Biosciences announced a collaboration with Mayo Clinic to develop and commercialize monoclonal microbials for the treatment of inflammatory and neuroinflammatory diseases.
New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic minorities and elderly patients
Mayo Clinic and the Massachusetts Institute of Technology (MIT) have been awarded a joint five-year, $9.7 million grant from the National Cancer Institute (NCI) to support a physical sciences-oncology center.